In contrast, sales revenues from Anti-malarial drugs are forecast to decline from Ush100.9 billion ($27 million) in 2024 to ...

Prospective homebuyers considering the real estate market had a range of options in various neighborhoods throughout the ...

For prospective homebuyers eyeing the real estate market in areas of Cumberland County, here's what sold for or under ...

Sage Therapeutics (NASDAQ:SAGE) has confirmed that the Alzheimer’s drug developer Biogen (NASDAQ:BIIB) has offered to buy all ...

Discover why Incyte's strong growth trajectory and upcoming product launches make it an attractive investment with a ...

The small-cap stock is available for trade on the BSE only. It ended on Friday with a market cap of ₹ 1,174 croreand a trade ...

Drugs would be cheaper if the big drug companies had to operate under the same rules applied to big insurance companies when ...

Ark Invest, led by Cathie Wood, made significant trades in 5 companies on Friday: RXRX, ILMN, NTLA, NET, and ADPT.

Fintel reports that on January 10, 2025, Cantor Fitzgerald initiated coverage of Bright Minds Biosciences (NasdaqCM:DRUG) with a Overweight recommendation. Analyst Price Forecast Suggests 77.07% ...

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

The problem of grocers selling underweighted meat and overcharging customers is prevalent and ongoing, a CBC News ...

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CRNX) today announced that on January 10, 2025, the Compensation ...